Genentech, Inc.
Time frame: 1 December 2022 - 30 November 2023Article ‘Count’ and ‘Share’ for Genentech, Inc. based on listed parameters only.
The articles listed below published by authors from Genentech, Inc., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
ACS Nano |
1 | 0.83 |
American Journal of Human Genetics |
1 | 0.05 |
American Journal of Respiratory and Critical Care Medicine |
1 | 0.04 |
Analytical Chemistry |
12 | 8.77 |
Blood |
1 | 0.10 |
Cancer Cell |
1 | 0.04 |
Cancer Research |
1 | 0.02 |
Cell |
2 | 0.71 |
Cell Stem Cell |
2 | 1.04 |
Chemical Communications |
1 | 0.33 |
Chemical Science |
3 | 0.46 |
Critical Care Medicine |
1 | 0.74 |
Gut |
1 | 0.83 |
Immunity |
1 | 0.05 |
Journal of Biological Chemistry |
1 | 1.00 |
Journal of Clinical Investigation |
1 | 0.04 |
Journal of Clinical Oncology |
3 | 0.34 |
Journal of Thoracic and Cardiovascular Surgery |
1 | 0.55 |
Journal of the American Chemical Society |
3 | 1.41 |
Journal of the American Society of Nephrology |
1 | 0.06 |
Nature |
9 | 2.09 |
Nature Biotechnology |
3 | 1.19 |
Nature Cell Biology |
1 | 0.06 |
Nature Chemical Biology |
1 | 1.00 |
Nature Communications |
17 | 5.64 |
Nature Genetics |
2 | 0.08 |
Nature Immunology |
1 | 0.05 |
Nature Medicine |
6 | 0.94 |
Nature Neuroscience |
2 | 0.21 |
Neuron |
1 | 0.81 |
Ophthalmology |
1 | 0.57 |
Organic Letters |
3 | 1.73 |
PLOS Genetics |
1 | 0.76 |
Proceedings of the National Academy of Sciences of the United States of America |
3 | 0.46 |
Science |
1 | 0.12 |
Science Advances |
4 | 1.19 |
Science Translational Medicine |
3 | 1.24 |
The EMBO Journal |
1 | 0.07 |
The Journal of Allergy and Clinical Immunology |
1 | 0.03 |
The Lancet |
3 | 0.39 |
The Lancet Oncology |
2 | 0.24 |
The New England Journal of Medicine |
2 | 0.34 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.